Real-Time Vision Diagnosis & Therapy
Leading the Way with AI-Driven Technology That’s Fast, Accurate and Portable
Through our cloud-based technology, you will be able to access vision tests and results real-time from any location, for immediate evaluation of vision defects. Vision augmentation applications are also in development. Our first product, a visual field test, is smart, fast and accurate.
With a wearable device and our software platform, you can quickly and easily take our visual field test as directed by your doctor. Your results are then immediately sent to your doctor for evaluation and diagnosis. This is the first of many tests being developed. Also in development, our vision augmentation application will enhance vision and help improve mobility.
Our Company Story
Heru is a spinoff company from the University of Miami’s Bascom Palmer Eye Institute.
Bascom Palmer is ranked the number one eye hospital in the U.S., and where our AI driven diagnostics and vision augmentation platform is in development.
Our technology is the culmination of a decade of clinical and scientific research and development, led by Heru’s Founder and visionary Mohamed Abou Shousha, MD, PhD, associate professor of clinical ophthalmology, Bascom Palmer Eye Institute, along with a team of leading physicians, scientists and engineers.
Learn More About Our Technology
Heru’s platform provides real-time diagnosis of vision disorders.
Our platform runs on mixed reality devices that can be used from any location. In development, our vision augmentation platform is designed to provide real-time vision correction.
“At Heru, we are developing an AI driven wearable technology that is intuitive, fast and portable. Our technology is designed to improve access to healthcare and bring eye health evaluation to the point-of-care, such as clinics, vision centers, retail pharmacies and at home.”
Mohamed Abou Shousha, MD, PhD, Heru’s Founder and CEO
“As a cloud-based technology, eye care providers will have instant access to Heru’s applications from any location. Now more than ever, we need technology that helps us quickly diagnose and manage our patients’ visual health.”
Maurice Ferré, MD